Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Authors
Publication date
1 January 2018
Publisher
HAL CCSD

Abstract

San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 05-09, 201

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archive Ouverte en Sciences de l'Information et de la Communication

    redirect
    oaioai:HAL:hal-02143680v1
    Last time updated on 09/07/2019

    HAL AMU

    redirect
    oaioai:HAL:hal-02143680v1
    Last time updated on 08/07/2019